Improvement of apathy in early Parkinson’s disease
Abstract Apathy is a disabling symptom in Parkinson’s disease (PD). The effect of dopaminergic treatment on apathy is inconsistent, depending on the stage of the disease, the type of apathy and strongly influenced by placebo effect. Our study assessed the evolution of a cohort of 86 de novo, drug na...
Saved in:
| Main Authors: | A. Castrioto, E. Schmitt, M. Anheim, S. Meoni, H. Klinger, D. Sourd, P. Pelissier, E. Lhommée, A. Bichon, C. Tranchant, E. Moro, V. Fraix, S. Thobois, P. Krack |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | npj Parkinson's Disease |
| Online Access: | https://doi.org/10.1038/s41531-025-00937-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deciphering the effects of STN DBS on neuropsychiatric fluctuations in Parkinson’s disease
by: Mari Muldmaa, et al.
Published: (2024-10-01) -
Apathy in Parkinson’s Disease: Diagnosis, Neuropsychological Correlates, Pathophysiology and Treatment
by: Gabriella Santangelo, et al.
Published: (2013-01-01) -
Noradrenergic deficits contribute to apathy in Parkinson's disease through the precision of expected outcomes.
by: Frank H Hezemans, et al.
Published: (2022-05-01) -
Diagnosis, treatment and management of apathy in Parkinson’s disease: a scoping review
by: Zahinoor Ismail, et al.
Published: (2020-09-01) -
Facial Emotion Recognition Impairment in Patients with Parkinson's Disease and Isolated Apathy
by: Mercè Martínez-Corral, et al.
Published: (2010-01-01)